Compare Enveric Biosciences Inc (ENVB) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Enveric Biosciences Inc trades at $1.41 (market cap $5.32M), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $12.35. The key difference: T-Rex 2X Inverse MSTR Daily Target ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | MSTZ | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $27.92 |
52-Week Low | $1.28 | $3.12 |
Enterprise Value | $408.82K | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
MSTZ is trading at $12.16, up 4.11% today, but technical indicators signal a bearish trend with moving averages and ADX suggesting selling pressure. The stock lacks disclosed financial ratios, and recent news highlights ETF performance unrelated to the company's fundamentals, indicating limited direct coverage.
The outlook is cautious due to weak technicals and absent fundamental data, posing risks for investors seeking growth. Opportunities may arise from undisclosed earnings improvements, but current sentiment and data gaps warrant careful evaluation amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
